Investment Summary

HealthEdge Investment Partners and Avante Capital Partners Invest In Radsource

On December 31, 2023, private equity firm HealthEdge Investment Partners and mezzanine finance firm Avante Capital Partners invested in healthcare services company Radsource

Investment Highlights
  • This is HealthEdge Investment Partners’ 7th and Avante Capital Partners’ 2nd transaction in the Healthcare Services sector.
  • This is HealthEdge Investment Partners’ 24th and Avante Capital Partners’ 28th transaction in the United States.
  • This is HealthEdge Investment Partners’ 1st and Avante Capital Partners’ 1st transaction in Tennessee.

Investment Summary

Date 2023-12-31
Target Radsource
Sector Healthcare Services
Investor(s) HealthEdge Investment Partners
Avante Capital Partners
Deal Type Growth Capital
Advisor(s) B.C. Ziegler and Co. (Financial)
Holland & Knight (Legal)

Target

Radsource

Brentwood, Tennessee, United States
Radsource provides clinical excellence in subspecialized musculoskeletal and neurological MRI interpretation. The company leverages its deep experience as radiologists and daily PACS users to deliver PACS solutions, ProtonPACS, to hospitals, imaging centers, physician practices, and various other medical imaging environments. Radsource is based in Brentwood, Tennessee.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

HealthEdge Investment Partners

Tampa, Florida, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2005
Size Small
Type Sector Focused
DESCRIPTION

HealthEdge Investment Partners is an operating-oriented private equity firm that targets the healthcare industry. The firm pursues buyouts, recapitalizations or structured investments in healthcare companies with a strong market share. HealthEdge targets businesses with enterprise value ranging between $10 million and $100 million, and with revenues ranging between $5 million and $75 million. Moreover, the firm looks for companies with EBITDA near $15 million. The firm typically commits between $5 million to $20 million of capital per company. HealthEdge focuses on the healthcare segments that involve medical products, devices and equipment, healthcare services, healthcare IT, pharmaceutical, and distribution. HealthEdge Investment Partners was founded in 2005 and is based in Tampa, Florida.


DEAL STATS #
Overall 24 of 24
Sector (Healthcare Services) 7 of 7
Type (Growth Capital) 8 of 8
State (Tennessee) 1 of 1
Country (United States) 24 of 24
Year (2023) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-04 P3 Oral Surgery

Charleston, West Virginia, United States

P3 Oral Surgery is an oral surgery service organization that provides business services such as revenue cycle management, purchasing, accounting & finance, marketing, human resources, and IT support. P3 Oral Surgery is based in Charleston, West Virginia.

Buy -
Investor

Avante Capital Partners

Los Angeles, California, United States

Investor Investor Investor Investor Investor


Category Mezzanine Finance Firm
Founded 2009
Size Small
Type Sector Agnostic
DESCRIPTION

Avante Mezzanine Partners is a provider of junior capital to lower middle-market companies generating at least $3 million in cash flow. The Firm looks to invest $5 to $20 million per transaction and generally works with private equity and independent sponsors in buyout transactions, as well as with entrepreneurs and owners to finance recapitalizations, refinancings, acquisitions and growth. Avante Mezzanine was formed in 2009 and has offices in Los Angeles and Boston.


DEAL STATS #
Overall 28 of 32
Sector (Healthcare Services) 2 of 3
Type (Growth Capital) 7 of 10
State (Tennessee) 1 of 1
Country (United States) 28 of 32
Year (2023) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-21 Monroe Biomedical Research

Monroe, North Carolina, United States

Monroe Biomedical Research offers a wide range of clinical trials, including investigations into treatments for pulmonary, metabolic, cardiological, psychiatric, and infectious diseases, as well as vaccine studies. Monroe Biomedical Research was founded in 2015 and is based in Monroe, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-19 Biologos

Montgomery, Illinois, United States

Biologos is a provider of sterile-filtered biological products (sera, reagents, buffers, cell culture media and other liquid solutions), primarily for veterinary pharmaceutical and organ transplant applications. Biologos was founded in 1976 and is based in Montgomery, Illinois.

Buy -